RUNX1 and acute myeloid leukemia: Here, we present the results of a large retrospective study on 674 patients, performed by the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) and designed specifically to analyze the prognostic value of RUNX1 mutation after allo SCT for AML.